重点短缺药品及供应保障措施探讨

目的：分析我国重点短缺药品品种，探讨供应保障措施，为缓解药品短缺和实施相关政策提供参考。方法：检索我国政府网站，收集整理短缺药品监测报告，从监测哨点角度、省级监测平台角度和短缺药品来源角度，总结归纳出我国重点短缺药品品种，分析其短缺原因，提出措施建议。结果与结论：我国短缺药品中，国产药品、化学药品占比较高，抗肿瘤药短缺问题突出，基本药物目录、医保目录内品种占比高。为做好短缺药品综合供应保障，应在落实已有政策的基础上，学习国外管理经验，着力解决重点短缺药品、完善监测平台、发挥政策引导作用，加强企业社会责任意识，做好数据挖掘和信息公开，多举措保障药品的可及性。

Discussion on Key Drugs in Shortage and Their Supply Safeguard Measures

Objective:To analyze the varieties of key drugs in shortage and discuss the supply safeguard measures in order to provide reference for alleviating the drug shortage and implementing relevant policies. Methods:Government websites were retrieved and monitoring reports about the drugs in shortage were collected and classified. The varieties of key drugs in shortage were further summarized from the perspective of sentinel surveillance, provincial monitoring platform and the source of the drug shortage. Meanwhile, the reasons for the shortage were analyzed and suggestions for supply were put forward. Results and Conclusion:Among the drugs in shortage in our country, the proportion of chemical drugs and domestic drugs was high, and the shortage of anti-tumor drugs was prominent. Most of the key drugs in shortage were included in the catalogue of essential medicines and medical insurance directory. In order to ensure the comprehensive supply of drugs in shortage, we should learn from foreign management experience on the basis of implementing existing policies, put emphasis on solving the problem of the key drugs in shortage, improve monitoring platforms, play the role of policy guidance, strengthen the social responsibility awareness of enterprises, and deepen the data mining and information disclosure. In short, multiple measures should be used to ensure the availability of drugs.